New study reveals how COVID-19 vaccine holds up in the elderly
NCT ID NCT04760704
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 22 times
Summary
This study looked at how strong and long-lasting the immune response from the COVID-19 vaccine is in elderly people living in care homes. Researchers compared their immune cells and antibody levels at 3 and 9 months after vaccination to those of younger adults aged 40-65. The goal was to understand if older adults get the same level of protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU lille
Lille, 59037, France
Conditions
Explore the condition pages connected to this study.